Sandoz spin-off continues Novartis’ focus on innovation; $22bn purchase rumoured
Novartis (Basel, Switzerland) has announced plans for a spin-off of its underperforming subsidiary, Sandoz, and will focus on innovative treatment…
Novartis (Basel, Switzerland) has announced plans for a spin-off of its underperforming subsidiary, Sandoz, and will focus on innovative treatment…
Pharma Technology Focus is now available on all devices. Read it for free here We look into the safety issues associated…
Pharma Technology Focus is now available on all devices. Read it for free here. In this issue we find out…
Pharma Technology Focus is now available on all devices. Read it for free here The top pharmaceutical companies have been…
Pharma Technology Focus is now available on all devices. Read it for free here. Personalised medicine has been hailed as a…
Pharma Technology Focus is now available on all devices. Read it for free here. Researchers from the University of Toronto have…
Pharma Technology Focus is now available on all devices. Read it for free here. Genentech has signed a $1bn open-ended drug…
Boehringer Ingelheim has added a new filling line to its Oasis facility in Shanghai, China in order to expand and…